Investor Relations –

Events &
Presentations

Presentations –

Presentations.

Date Title Files
Oct 6, 2026
Inaugural Investor/ Analyst Day Presentation October 2026
PDF
Oct 6, 2026
Faeth Corporate Presentation October 2026
PDF
Aug 8, 2026
Exposure/Response Analysis of an Oral Multi-Node PI3K/AKT/mTOR Pathway Inhibitor Combination of Serabelisib and Sapanisertib
PDF
Events –

Past events.

Oct
06
2026
Virtual KOL Event: Multi-Nodal Inhibition for the Treatment of Endometrial Cancer
Supporting Materials
Click here for webcast
Sep
16
2026
Morgan Stanley 24th Annual Global Healthcare Conference
Click here for webcast
Sep
10
2026
Cantor Global Healthcare Conference 2026
Click here for webcast
Apr
16
2026
25th Annual Needham Virtual Healthcare Conference
Click here for webcast
Feb
18
2026
Sensei Acquisition of Faeth Therapeutics
Click here for webcast

The drug product candidates described on this website are investigational agents that have not been approved by the Food and Drug Administration or any other regulatory authority. Their safety and efficacy have not been established.